BP1002

· Bio-Path Holdings, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BP1002, covering 2025-02-24 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML) [Phase 1]